Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: Preliminary analysis of the results of the IMPACT study

Anita V. Mitra, Elizabeth K. Bancroft, Yolanda Barbachano, Elizabeth C. Page, C. S. Foster, C. Jameson, G. Mitchell, G. J. Lindeman, A. Stapleton, G. Suthers, D. G. Evans, D. Cruger, I. Blanco, C. Mercer, J. Kirk, L. Maehle, S. Hodgson, L. Walker, L. Izatt, F. DouglasK. Tucker, H. Dorkins, V. Clowes, A. Male, A. Donaldson, C. Brewer, R. Doherty, B. Bulman, P. J. Osther, M. Salinas, D. Eccles, K. Axcrona, I. Jobson, B. Newcombe, C. Cybulski, W. S. Rubinstein, S. Buys, S. Townshend, E. Friedman, S. Domchek, T. Ramon Y Cajal, A. Spigelman, S. H. Teo, N. Nicolai, N. Aaronson, A. Ardern-Jones, C. Bangma, D. Dearnaley, J. Eyfjord, A. Falconer, F. Hamdy, O. Johannsson, V. Khoo, Z. Kote-Jarai, H. Lilja, J. Lubinski, J. Melia, C. Moynihan, S. Peock, G. Rennert, F. Schröder, P. Sibley, M. Suri, P. Wilson, Y. J. Bignon, S. Strom, M. Tischkowitz, A. Liljegren, D. Ilencikova, A. Abele, K. Kyriacou, C. Van Asperen, L. Kiemeney, D. F. Easton, Rosalind A. EelesShow 55 moreShow less